Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Philips Healthcare; Accenture
ANDOVER, Mass. and NEW YORK, Oct. 3, 2013 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) and Accenture (NYSE: ACN) today announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing physicians with hands-free access to critical clinical information.
The new concept demonstration depicts how a doctor wearing the display could simultaneously monitor a patient's vital signs and react to surgical procedural developments without having to turn away from the patient or procedure. A physician could also monitor a patient's vital signs remotely or enlist assistance from doctors in other locations.
"We live in a world where being nimble is key and industry-altering ideas need to be converted to practical solutions that people can use," said Michael Mancuso, CEO, Patient Care and Clinical Informatics at Philips Healthcare. "This research explores how doctors can achieve better access to the right information at the right time so they can focus on more efficient and effective patient care. It's a first step in researching how existing technologies can be applied to improve the quality of life of patients."
Researchers from Philips' newly created 'Digital Accelerator Lab,' a cross-sector innovation platform with labs based in the Netherlands and India, collaborated with researchers from Accenture Technology Labs to explore the potential use of Google Glass in clinical settings. The goal was to create the first proof of concept for Google Glass and Philips IntelliVue Solutions and then to begin exploring additional opportunities to integrate Google Glass seamlessly with Philips healthcare solutions.
"Accenture's work with Philips showcases a powerful use of wearable devices in the healthcare industry, helping physicians perform their jobs more effectively and enhancing care for patients," said Paul Daugherty, chief technology officer, Accenture. "This exciting work highlights the potential of digital technologies to transform the way we work and live, and we're pleased to have collaborated with Philips to help bring this vision to life."
Aside from the possibility of operating in a hands-free environment, the Google Glass IntelliVue Solution research effort was developed to explore how to enhance a clinician's mobility by allowing the seamless transfer of patient information while on the go. Further research may indicate how to possibly enable clinicians to keep their focus on the patient while simultaneously obtaining a live view of critical patient monitoring data.
Additional topics for research may include:
The Philips Digital Accelerator Lab underlines Philips' commitment to developing innovative solutions across the care continuum, to improve patient outcomes, provide better value and expand access to care. Today, Philips offers a comprehensive portfolio of patient monitoring solutions ranging from bedside monitors to wearable patient monitors, combined with clinical decision support tools and mobile applications to provide immediate access to centrally held patient data. More than 190 million patients are monitored each year with Philips' patient monitors.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013. Its home page is www.accenture.com.
Video with caption: "Philips collaborates with Accenture to create first proof of concept for delivering vital patient data via Google Glass." Video available at: http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/FX-MM91256-20131002-1.mp4
Image with caption: "Anesthesiologist Dr. Feinstein in an OR simulator lab tests viewing IntelliVue vital signs via Google Glass." Image available at: http://photos.prnewswire.com/prnh/20131003/MM91256-a
Image with caption: "Developers Divya Mahajan from Philips and Brent Blum from Accenture instruct Dr. David Feinstein in how to use the Google Glass connected to IntelliVue monitoring."
Image available at: http://photos.prnewswire.com/prnh/20131003/MM91256-b
Image with caption: "Anesthesiologist's view of IntelliVue vital signs via Google Glass in an OR simulator lab test." Image available at: http://photos.prnewswire.com/prnh/20131003/MM91256-c
Image with caption: "The anesthesiologist can keep their attention on the patient while also maintaining a view of IntelliVue vital signs via Google Glass as seen in this OR simulator lab test." Image available at: http://photos.prnewswire.com/prnh/20131003/MM91256-d
©2012 PR Newswire. All Rights Reserved.